US2005043242A1PendingUtilityA1

Method for treating or preventing Alzheimer's disease

50
Assignee: R W ESMONDPriority: Mar 12, 1997Filed: Sep 9, 2004Published: Feb 24, 2005
Est. expiryMar 12, 2017(expired)· nominal 20-yr term from priority
Inventors:Robert EsmondJack R. WandsSuzanne De La Monte
A61P 3/10A61P 5/00A61K 31/28A61K 38/30A61K 31/00A61K 31/4439A61K 31/4985A61K 31/48A61K 31/427A61P 25/28A61K 31/426A61K 33/24
50
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Disclosed is a method for treating or preventing Alzheimer's disease by restricting the level of metabolizable carbohydrate in the diet and/or administering to the patient an effective amount of an agent which reduces serum insulin levels.

Claims

exact text as granted — not AI-modified
1 - 20 . (cancelled)  
     
     
         21 . A method for the treatment of Alzheimer's disease, in a human, comprising administering to the human in need thereof an effective amount of troglitazone.  
     
     
         22 . A method for the treatment of Alzheimer's disease, in a human, comprising administering to the human in need thereof an effective amount of troglitazone or a pharmaceutically acceptable salt thereof.  
     
     
         23 . A method for the treatment of Alzheimer's disease, in a human, comprising administering to the human in need thereof an effective amount of pioglitazone.  
     
     
         24 . A method for the treatment of Alzheimer's disease, in a human, comprising administering to the human in need thereof an effective amount of pioglitazone hydrochloride.  
     
     
         25 . A method for the treatment of Alzheimer's disease, in a human, comprising administering to the human in need thereof an effective amount of pioglitazone or a pharmaceutically acceptable salt thereof.  
     
     
         26 . A method of improving mentation of a patient with Alzheimer's disease, comprising administering to said patient an effective amount of pioglitazone.  
     
     
         27 . A method of improving mentation of a patient with Alzheimer's disease, comprising administering to said patient an effective amount of pioglitazone hydrochloride.  
     
     
         28 . A method of improving mentation of a patient with Alzheimer's disease, comprising administering to said patient an effective amount of pioglitazone or a pharmaceutically acceptable salt thereof.  
     
     
         29 . A method of improving mentation of a patient with Alzheimer's disease, comprising administering to said patient an effective amount of troglitazone or a pharmaceutically acceptable salt thereof.

Join the waitlist — get patent alerts

Track US2005043242A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.